TFIIB Antibody [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-49981F
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunoprecipitation, Western Blot (Negative)
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for TFIIB Antibody [FITC]
Immunogen
The immunogen for this product maps to a region between residue 100 and 150 of human General Transcription Factor IIB using the numbering given in entry NP_001505.1 (GeneID 2959).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for TFIIB Antibody [FITC]
Application
Recommended Usage
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot (Negative)
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: TFIIB
Alternate Names
general transcription factor IIB, General transcription factor TFIIB, S300-II, TFIIBTF2BRNA polymerase II transcription factor IIB, transcription initiation factor IIB
Gene Symbol
GTF2B
Additional TFIIB Products
Product Documents for TFIIB Antibody [FITC]
Product Specific Notices for TFIIB Antibody [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...